HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter de Vries Selected Research

2-acylglycerophosphate acyltransferase

11/2006Antileukemic activity of lysophosphatidic acid acyltransferase-beta inhibitor CT32228 in chronic myelogenous leukemia sensitive and resistant to imatinib.
12/2003Antitumor activity of lysophosphatidic acid acyltransferase-beta inhibitors, a novel class of agents, in multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter de Vries Research Topics

Disease

6Neoplasms (Cancer)
01/2020 - 10/2003
2Overactive Urinary Bladder (Overactive Bladder)
11/2021 - 09/2017
2Prostatic Neoplasms (Prostate Cancer)
01/2021 - 10/2017
1Lymphatic Metastasis
04/2022
1Urinary Bladder Neoplasms (Bladder Cancer)
04/2022
1Breast Neoplasms (Breast Cancer)
01/2020
1Infections
01/2016
1Tuberculosis (Tuberculoses)
11/2010
1Extensively Drug-Resistant Tuberculosis
11/2010
1Human Influenza (Influenza)
11/2010
1Legionnaires' Disease (Legionnaire's Disease)
11/2010
1Leukemia
11/2006
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2006
1Multiple Myeloma
12/2003
1Carcinogenesis
10/2003
1Migraine Disorders (Migraine)
03/2003

Drug/Important Bio-Agent (IBA)

4Pharmaceutical PreparationsIBA
10/2017 - 11/2006
2incobotulinumtoxinAFDA Link
11/2021 - 09/2017
2AndrogensIBA
01/2021 - 10/2017
2Histones (Histone)IBA
01/2018 - 10/2017
22-acylglycerophosphate acyltransferaseIBA
11/2006 - 12/2003
2Phosphatidic Acids (Phosphatidic Acid)IBA
12/2003 - 10/2003
1onabotulinum toxin AIBA
11/2021
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2020
1Trastuzumab (Herceptin)FDA Link
01/2020
1tucatinibIBA
01/2020
1Tyrosine Kinase InhibitorsIBA
01/2020
1Docetaxel (Taxotere)FDA Link
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2018
1CREB-Binding ProteinIBA
10/2017
1Androgen Receptors (Androgen Receptor)IBA
10/2017
1Histone Acetyltransferases (Histone Acetyltransferase)IBA
10/2017
1Histone Deacetylase InhibitorsIBA
10/2017
1Type A Botulinum Toxins (Botox)FDA Link
09/2017
1AntibodiesIBA
01/2016
1PolymersIBA
03/2007
1Paclitaxel (Taxol)FDA LinkGeneric
03/2007
1Cathepsin BIBA
03/2007
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2006
1Imatinib Mesylate (Gleevec)FDA Link
11/2006
1Protein Isoforms (Isoforms)IBA
12/2003
1lysophosphatidic acidIBA
12/2003
1LY 344864IBA
03/2003
1Serotonin (5 Hydroxytryptamine)IBA
03/2003
1Vasoconstrictor AgentsIBA
03/2003
1Tryptamines (Triptans)IBA
03/2003
1Neurotransmitter Agents (Neurotransmitter)IBA
03/2003

Therapy/Procedure

2Therapeutics
01/2021 - 10/2003
1Cystectomy
04/2022
1Lymph Node Excision (Lymph Node Dissection)
04/2022
1Injections
11/2021
1Radiotherapy
01/2021
1Castration
10/2017
1Intravesical Administration
09/2017